Page 26 - Sohini Das

Bajaj Auto's affordable Chetak 2901 charges up electric scooter market

Major players hold 80% of sub-Rs 1L e-scooter segment, against 50-60% a yr ago

Dr Reddy's Laboratories eyes acquisitions to drive growth in India

The share of chronic has been steadily rising in the Rs 2 lakh crore domestic pharma market- from 36.4 percent in January 2022 to 38.1 percent in January 2024

Changing colours of succession: India Inc is learning to deal with GenNext

The key issues to be ironed out in succession are an unambiguous allocation of properties among legal heirs and the timeline for vesting of these properties

Tamil Nadu likely to be hub for Tata Motors-JLR's electric vehicle exports

Tata Motors is working on multiple options at the plant, where it plans to invest Rs 9,000 crore over five years

Tata Motors electric vehicle business posts Rs 9,300 crore revenue in FY24

Co expects PV industry demand to moderate as a result of high base effect

Charging ahead: Focus on net carbon zero, says TaMo's Shailesh Chandra

"Frankly, Tata Motors has no dilemma around which technology to invest in. We have to watch for the long-term mega trends since there will be many intermittent confusions and distractions"

US, UK in focus as pharma companies eye $31 billion exports in FY25

Industry also working to pump up business in Africa and Russia, regions battling geopolitical crises

Patient safety outfit files PIL against 'dumping' of used medical devices

The domestic lobby felt that local manufacturers who stepped forward to make these devices in India under PLI are left dismayed as a result

Deepening presence in Tier-III may be Dr Lal PathLabs' growth pill

Manchanda highlights that the 'white-spaces' for them are going deeper in strong markets

Indian pharmaceutical companies likely to cash in on US drug shortages

US drug shortages hit a decade-high of 323 across 22 therapies in the March quarter of 2024

Second-gen promoters more open to selling out: Rothschild MD Subhakanta Bal

In pharma areas like high potency APIs, sterile manufacturing capabilities, antibody drug conjugates, peptides etc are areas that are growing fast and there is an inherent entry barrier

India to make JLR's Range Rover for first time, delivery starts May 24

Prices of 'flagship car' and its sport variant will reduce by 18-22%, say senior executives of Tata Motors-owned company

On the path to carbon neutrality, six EVs to come in 4 years: JLR India MD

We have the full EV starting with the Range Rover around the end of next year, Amba said

US-based firm Taro's shareholders approve merger with Sun Pharmaceutical

The merger agreement between Sun Pharma and Taro was approved by an affirmative vote of Taro shareholders at an extraordinary general meeting and an ordinary class meeting on May 22

Moved imp products out of Mohali, Dadra plants: Sun Pharma's Abhay Gandhi

Speaking to Sohini Das over a video interview from the US, Abhay Gandhi, CEO, North America of Sun Pharma outlines his plan for the company's specialty business

Sun Pharma Q4 result: Profit up 33% over strong US, specialty sales

Firm guides for high single-digit top line, higher R&D spend in FY25; board approves appointment of Dilip Shanghvi as chairman

Serum Institute ships its first set of malaria vaccine doses to Africa

The vaccine has been developed in collaboration with the University of Oxford and Novavax's Matrix-M adjuvant

Covid vaccine makers gear up to launch new-generation jabs in India

India currently does not have any XBB 1.5 variant-based vaccines in the market

Tata Motors to invest Rs 43,000 crore in products and technologies in FY25

Analysts expect JLR margins to remain stable

Fuelling change? M&M may consider hybrid tech shift if demand arises

Automaker puts EVs and ICE in the driver's seat amid hybrid emission concerns